StockData
Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc. (ALDX) stock

ALDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.69+0.02 (+3.63%)

Close on Nov 17, 2026Market cap $41.86MP/E –Yield –

Earnings

Aldeyra Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q1 FY2023
–
EPS, Q1 FY2023
-$0.27
-$0.29 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Aldeyra Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q1 FY2023ended Mar 31, 2023May 4, 2023before the open––-$0.27Release
Q4 FY2022ended Dec 31, 2022Mar 9, 2023before the open–––Release
Q3 FY2022ended Sep 30, 2022Nov 10, 2022before the open––-$0.25Release
Q2 FY2022ended Jun 30, 2022Aug 5, 2022before the open––-$0.30Release
Q1 FY2022ended Mar 31, 2022May 5, 2022before the open––-$0.29Release
Q4 FY2021ended Dec 31, 2021Mar 17, 2022before the open–––Release
Q3 FY2021ended Sep 30, 2021Oct 28, 2021before the open––-$0.27Release
Q2 FY2021ended Jun 30, 2021Aug 5, 2021before the open–––Filing
Q1 FY2021ended Mar 31, 2021May 6, 2021before the open–––Filing
Q4 FY2020ended Dec 31, 2020Mar 11, 2021before the open–––Filing
Q3 FY2020ended Sep 30, 2020Nov 5, 2020before the open–––Filing
Q2 FY2020ended Jun 30, 2020Aug 6, 2020before the open–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Aldeyra Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Aldeyra Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Aldeyra Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. Update
  3. Update
  4. Update
  5. Update
  6. Update
  7. Update
  8. Update
  9. News
  10. News
  11. Update
  12. News
  13. Update
  14. Update
  15. Update

See a number that looks wrong?